After a great response to Acute Myeloid Leukemia World Awareness Day (AML WAD) in 2020, Know AML looks forward to commemorating AML WAD in 2021. This year, Know AML is also excited to be launching a new AML animation series for patients, families, and caregivers.
AML WAD will take place on April 21, 2021, with the aim to facilitate and improve knowledge of AML worldwide through collaborative participation. Know AML is excited to lead the campaign through a series of coordinated activities: Personalize it, Share it, Wear it, and Find it.
There are different ways to get involved in AML WAD, both on social media and through offline activities. Know AML would like to encourage everyone to participate! Personalize your social media profile using our digital banners; share our new animations with family and friends; wear red and black and share a selfie on social media; find
AML-associated words in the Know AML word search puzzle, and share a selfie with your completed word search on social media. Our banners and word search puzzles are available in multiple languages, to get as many supporters as possible involved globally. Join the conversation on social media using the official hashtag #KnowAML. Visit http://www.know-aml.com/en/get-involved/world-awareness-day for more information about how to participate.
On AML WAD, Know AML will launch a series of four new animations to provide information for patients with AML, families, and caregivers. Previous topics include an overview of AML, signs and symptoms, diagnosis, AML types, treatment overview, clinical trials, and remission. This year, Know AML have put together animations focused on relapse in AML, refractory AML, measurable residual disease, and risk stratification. These animations will be available for you to share on social media using the official hashtag #KnowAML. Please encourage your friends, family, and networks to do the same!
Know AML are proud to work alongside professional organizations that help to distribute resources and knowledge to the AML community worldwide, and we remain grateful for their unsurpassed support.
About Know AML
Know AML is the first global AML initiative that aims to direct patients, carers, families, and healthcare professionals to the available information, resources, and support they need to deal with AML. Know AML collaborates with a vast, global network of advocates, who together ensure that the AML community has access to the latest information and resources, providing the best possible support and care for patients with AML and their families.
To drive awareness of AML globally through community collaborations, while continuing to raise awareness of the resources and support currently available. Know AML aspires to facilitate and improve knowledge of AML worldwide and develop community-based initiatives to overcome current and future challenges.
Know AML is a global initiative steered by an independent, multidisciplinary ambassador group who provide guidance on the development of educational and support materials. The Know AML ambassador group includes representatives from the following AML communities: patients, families, specialist nurses, patient advocacy representatives, leading physicians in AML, and official Know AML supporters.
Know AML would like to thank its 2021 industry partners: AbbVie (Gold), Amgen (Gold), Astellas (Silver), Bristol Myers Squibb (Silver), Jazz Pharmaceuticals (Silver), and Novartis (Contributor).
Know AML is brought to you by Scientific Education Support (SES), whose aim is to facilitate education through collaboration by building communities and networks to ensure that patients have access to the latest support and treatments options.
For media enquires or to get involved, please contact us: firstname.lastname@example.org
For more information, please visit our webpage: www.know-aml.com
Follow us on social media: Twitter: @KNOW_AML; Facebook: @KNOWAML; Instagram: @knowaml; LinkedIn: know-aml
Press release distributed by Pressat on behalf of Scientific Education Support, on Wednesday 17 March, 2021. For more information subscribe and follow https://pressat.co.uk/